121 related articles for article (PubMed ID: 16455054)
1. Subcellular localization and regulation of type-1C and type-5 phosphodiesterases.
Dolci S; Belmonte A; Santone R; Giorgi M; Pellegrini M; Carosa E; Piccione E; Lenzi A; Jannini EA
Biochem Biophys Res Commun; 2006 Mar; 341(3):837-46. PubMed ID: 16455054
[TBL] [Abstract][Full Text] [Related]
2. Regulation of phosphodiesterase 5 expression and activity in human pregnant and non-pregnant myometrial cells by human chorionic gonadotropin.
Belmonte A; Ticconi C; Dolci S; Giorgi M; Zicari A; Lenzi A; Jannini EA; Piccione E
J Soc Gynecol Investig; 2005 Dec; 12(8):570-7. PubMed ID: 16325746
[TBL] [Abstract][Full Text] [Related]
3. The role of phosphodiesterase isoforms 2, 5, and 9 in the regulation of NO-dependent and NO-independent cGMP production in the rat cervical spinal cord.
de Vente J; Markerink-van Ittersum M; Vles JS
J Chem Neuroanat; 2006 Jun; 31(4):275-303. PubMed ID: 16621445
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular implications in the use of PDE5 inhibitor therapy.
Maurice DH
Int J Impot Res; 2004 Jun; 16 Suppl 1():S20-3. PubMed ID: 15224131
[TBL] [Abstract][Full Text] [Related]
5. Expression and functional activity of phosphodiesterase type 5 in human and rabbit vas deferens.
Mancina R; Filippi S; Marini M; Morelli A; Vignozzi L; Salonia A; Montorsi F; Mondaini N; Vannelli GB; Donati S; Lotti F; Forti G; Maggi M
Mol Hum Reprod; 2005 Feb; 11(2):107-15. PubMed ID: 15640438
[TBL] [Abstract][Full Text] [Related]
6. Platelet-derived growth factor regulation of type-5 phosphodiesterase in human and rat penile smooth muscle cells.
Carosa E; Castri A; Forcella C; Sebastiani G; Di Sante S; Gravina GL; Ronchi P; Cesarini V; Dolci S; Di Stasi S; Lenzi A; Jannini EA
J Sex Med; 2014 Jul; 11(7):1675-84. PubMed ID: 24836457
[TBL] [Abstract][Full Text] [Related]
7. Expression and regulation of the cGMP-binding, cGMP-specific phosphodiesterase (PDE5) in human colonic epithelial cells: role in the induction of cellular refractoriness to the heat-stable enterotoxin peptide.
Bakre MM; Sopory S; Visweswariah SS
J Cell Biochem; 2000 Feb; 77(1):159-67. PubMed ID: 10679826
[TBL] [Abstract][Full Text] [Related]
8. The cGMP-binding, cGMP-specific phosphodiesterase (PDE5): intestinal cell expression, regulation and role in fluid secretion.
Sopory S; Kaur T; Visweswariah SS
Cell Signal; 2004 Jun; 16(6):681-92. PubMed ID: 15093609
[TBL] [Abstract][Full Text] [Related]
9. Cyclic GMP phosphodiesterases and regulation of smooth muscle function.
Rybalkin SD; Yan C; Bornfeldt KE; Beavo JA
Circ Res; 2003 Aug; 93(4):280-91. PubMed ID: 12933699
[TBL] [Abstract][Full Text] [Related]
10. Cyclic nucleotide phosphodiesterase (PDE) inhibitors: novel therapeutic agents for progressive renal disease.
Cheng J; Grande JP
Exp Biol Med (Maywood); 2007 Jan; 232(1):38-51. PubMed ID: 17202584
[TBL] [Abstract][Full Text] [Related]
11. Calmodulin-stimulated cyclic nucleotide phosphodiesterase (PDE1C) is induced in human arterial smooth muscle cells of the synthetic, proliferative phenotype.
Rybalkin SD; Bornfeldt KE; Sonnenburg WK; Rybalkina IG; Kwak KS; Hanson K; Krebs EG; Beavo JA
J Clin Invest; 1997 Nov; 100(10):2611-21. PubMed ID: 9366577
[TBL] [Abstract][Full Text] [Related]
12. Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility.
Nagendran J; Archer SL; Soliman D; Gurtu V; Moudgil R; Haromy A; St Aubin C; Webster L; Rebeyka IM; Ross DB; Light PE; Dyck JR; Michelakis ED
Circulation; 2007 Jul; 116(3):238-48. PubMed ID: 17606845
[TBL] [Abstract][Full Text] [Related]
13. Improving erectile function by silencing phosphodiesterase-5.
Lin G; Hayashi N; Carrion R; Chang LJ; Lue TF; Lin CS
J Urol; 2005 Sep; 174(3):1142-8. PubMed ID: 16094082
[TBL] [Abstract][Full Text] [Related]
14. Phosphodiesterase 5 in the female pig and human urethra: morphological and functional aspects.
Werkström V; Svensson A; Andersson KE; Hedlund P
BJU Int; 2006 Aug; 98(2):414-23. PubMed ID: 16626307
[TBL] [Abstract][Full Text] [Related]
15. Phosphodiesterase regulation of nitric oxide signaling.
Kass DA; Takimoto E; Nagayama T; Champion HC
Cardiovasc Res; 2007 Jul; 75(2):303-14. PubMed ID: 17467673
[TBL] [Abstract][Full Text] [Related]
16. Phosphodiesterase type 5 inhibition improves early memory consolidation of object information.
Prickaerts J; Sik A; van Staveren WC; Koopmans G; Steinbusch HW; van der Staay FJ; de Vente J; Blokland A
Neurochem Int; 2004 Nov; 45(6):915-28. PubMed ID: 15312986
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide-evoked transient kinetics of cyclic GMP in vascular smooth muscle cells.
Cawley SM; Sawyer CL; Brunelle KF; van der Vliet A; Dostmann WR
Cell Signal; 2007 May; 19(5):1023-33. PubMed ID: 17207606
[TBL] [Abstract][Full Text] [Related]
18. PDE4 and PDE5 regulate cyclic nucleotides relaxing effects in human umbilical arteries.
Santos-Silva AJ; Cairrão E; Morgado M; Alvarez E; Verde I
Eur J Pharmacol; 2008 Mar; 582(1-3):102-9. PubMed ID: 18234184
[TBL] [Abstract][Full Text] [Related]
19. [Cyclic nucleotide content of the rabbit myometrium in various functional states].
Kondratiuk TP; babich LG; Osipenko AA; Bychenok SF; Kurskiĭ MD
Vopr Med Khim; 1985; 31(2):55-9. PubMed ID: 2988202
[TBL] [Abstract][Full Text] [Related]
20. Developmental changes in lung cGMP phosphodiesterase-5 activity, protein, and message.
Hanson KA; Burns F; Rybalkin SD; Miller JW; Beavo J; Clarke WR
Am J Respir Crit Care Med; 1998 Jul; 158(1):279-88. PubMed ID: 9655741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
